Moxetumomab Pasudotox-tdfk and Mycophenolate Suspension
Determining the interaction of Moxetumomab Pasudotox-tdfk and Mycophenolate Suspension and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: mycophenolate mofetil
Brand name: Cellcept, Myfortic, MMF
Synonyms: Mycophenolate mofetil (oral/injection), Mycophenolate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Mycophenolate Tablets
- Moxetumomab Pasudotox-tdfk-Mycophenolate Tablets Delayed Release
- Moxetumomab Pasudotox-tdfk-Mycophenolic acid
- Moxetumomab Pasudotox-tdfk-Mycophenolic Acid Delayed-Release Tablets
- Moxetumomab Pasudotox-tdfk-Mycophenolic Acid Tablets
- Moxetumomab Pasudotox-tdfk-Mycostatin (Nystatin Oral Suspension)
- Mycophenolate Suspension-Moxetumomab pasudotox-tdfk Intravenous
- Mycophenolate Suspension-Moxifloxacin
- Mycophenolate Suspension-Moxifloxacin (Systemic)
- Mycophenolate Suspension-Moxifloxacin Hydrochloride
- Mycophenolate Suspension-Moxifloxacin Injection
- Mycophenolate Suspension-Moxifloxacin Intravenous